Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A prospective and multicenter safety-monitoring study of a short up-dosing schedule of immunotherapy with a mass-units-standardized extract of mites.
Gamboa P, González G, Jauregui I, Jorró G, Molero I, Eseverri JL, González R, Luna I, Marcos C, Miró J, Pulido Z, Gracia T, Iriarte P, Carreño A, Navarro JA, Rocafort S, García-Robaina JC, Souto I, Casas R, Lleonart R, Nevot S, Asensio O, Bosque M, Blasco A, de la Torre F. Gamboa P, et al. Among authors: de la torre f. Allergol Immunopathol (Madr). 2004 Jan-Feb;32(1):13-7. doi: 10.1016/s0301-0546(04)79217-4. Allergol Immunopathol (Madr). 2004. PMID: 14980190
Tolerance and short-term effect of a cluster schedule with pollen-extracts quantified in mass-units.
Guardia P, Moreno C, Justicia JL, Conde J, Cimarra M, Díaz M, Guerra F, Martínez-Cócera C, Gonzalo-Garijo MA, Pérez-Calderón R, González-Quevedo T, Sánchez-Cano M, Vigaray J, Acero S, Blanco R, Martín S, de la Torre F. Guardia P, et al. Among authors: de la torre f. Allergol Immunopathol (Madr). 2004 Sep-Oct;32(5):271-7. doi: 10.1016/s0301-0546(04)79254-x. Allergol Immunopathol (Madr). 2004. PMID: 15456623 Clinical Trial.
Comparison of two diagnostic techniques, skin-prick test and component resolved diagnosis in the follow-up of a cohort of paediatric patients with pollinosis. Multicentre pilot study in a highly exposed allergenic area.
González-Mancebo E, Domínguez-Ortega J, Blanco-Bermejo S, González-Seco E, Trujillo MJ, de la Torre F; ESPLORA Group. González-Mancebo E, et al. Among authors: de la torre f. Allergol Immunopathol (Madr). 2017 Mar-Apr;45(2):121-126. doi: 10.1016/j.aller.2016.04.005. Epub 2016 Jul 28. Allergol Immunopathol (Madr). 2017. PMID: 27477032
Tolerance of a cluster schedule on the treatment of seasonal allergic respiratory disease with pollen extracts quantified in mass units.
Moreno C, Fernández-Távora L, Acero S, Alonso MD, Barasona MJ, Blanco R, Cisteró A, Conde J, Fernández J, Fernández S, Fernández-Rivas M, García BE, García-Rodríguez R, Camacho E, González-Quevedo T, Gonzalo A, Guardia P, Sánchez-Cano M, Tabar AI, de la Torre F. Moreno C, et al. Among authors: de la torre f. J Investig Allergol Clin Immunol. 2003;13(4):221-7. J Investig Allergol Clin Immunol. 2003. PMID: 14989109
Postmarketing study for assessment of tolerability of a grass allergen immunotherapy tablet (GRAZAX) in patients with rhinitis or rhinoconjunctivitis.
Armentia A, Carballada F, Carretero P, de Paz S, Lobera T, Marcos C, Martínez JC, Rodríguez I, Soto T, Venturini M, de la Torre F. Armentia A, et al. Among authors: de paz s, de la torre f. J Investig Allergol Clin Immunol. 2012;22(7):485-90. J Investig Allergol Clin Immunol. 2012. PMID: 23397670 Free article.
Assessment of short-term changes induced by a Dermatophagoides pteronyssinus extract on asthmatic patients. Randomised, double-blind, placebo-controlled trial.
Vidal C, Tabar AI, Figueroa J, Navarro JA, Sánchez C, Orovitg A, Armisen M, Echechipía S, Joral A, Lizarza S, Lizaso MT, Rodriguez V, de la Torre F. Vidal C, et al. Among authors: de la torre f. Curr Drug Deliv. 2011 Mar;8(2):152-8. doi: 10.2174/156720111794479871. Curr Drug Deliv. 2011. PMID: 21235477 Clinical Trial.
171 results